|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 1 (January 1), 1999:
pp. 140-148
Heparan Sulfate Proteoglycans Mediate Interleukin-7- Dependent B
Lymphopoiesis
Lisa A. Borghesi,
Yoshio Yamashita, and
Paul W. Kincade
From the Oklahoma Medical Research Foundation, Immunobiology and
Cancer Program, Oklahoma City.
Heparin/heparan sulfate proteoglycans (HSPGs) have the potential to
bind and directly regulate the bioactivity of hematopoietic growth
factors including interleukin-7 (IL-7), a cytokine critical for murine
B-cell development. We examined the consequence of manipulating soluble
heparin and cell-surface heparan sulfate to IL-7-dependent responses
of B-cell precursors. Soluble heparin was found to inhibit production
of lymphoid, but not myeloid, cells in long-term bone marrow cultures.
Analysis of pro-B cells lacking plasma membrane HS suggests that this
glycosaminoglycan is required for efficient binding and responsiveness
to IL-7. By contrast, responses of hematopoietic cells to other
cytokines were not influenced by heparin addition or HS removal.
Therefore, HSPGs on B-lineage precursors may function as IL-7 receptor
components similar to HSPGs known to be important for the bFGF
receptor. Other experiments suggest that HSPGs on the surface of
stromal cells provide a weakly associating docking site for IL-7,
possibly controlling availability of this cytokine to B-cell
precursors. Together these data demonstrate a direct role for
heparinlike molecules in regulating the IL-7-dependent stages of
murine B lymphopoiesis.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. den Dekker, S. Grefte, T. Huijs, G. B. ten Dam, E. M. M. Versteeg, L. C. J. van den Berk, B. A. Bladergroen, T. H. van Kuppevelt, C. G. Figdor, and R. Torensma
Monocyte Cell Surface Glycosaminoglycans Positively Modulate IL-4-Induced Differentiation toward Dendritic Cells
J. Immunol.,
March 15, 2008;
180(6):
3680 - 3688.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Milne, S. A. Corfe, and C. J. Paige
Heparan Sulfate and Heparin Enhance ERK Phosphorylation and Mediate preBCR-Dependent Events during B Lymphopoiesis
J. Immunol.,
March 1, 2008;
180(5):
2839 - 2847.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Chung, E. P. Dudl, D. Min, L. Barsky, N. Smiley, and K. I. Weinberg
Prevention of graft-versus-host disease by anti IL-7R{alpha} antibody
Blood,
October 15, 2007;
110(8):
2803 - 2810.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Fluur, A. De Milito, T. J. Fry, N. Vivar, L. Eidsmo, A. Atlas, C. Federici, P. Matarrese, M. Logozzi, E. Rajnavolgyi, et al.
Potential Role for IL-7 in Fas-Mediated T Cell Apoptosis During HIV Infection
J. Immunol.,
April 15, 2007;
178(8):
5340 - 5350.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Lai, R. A. Zeff, and I. Goldschneider
A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and pre-pro-B cells
Blood,
March 1, 2006;
107(5):
1776 - 1784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Johnson, N. Shah, A. Panoskaltsis-Mortari, and T. W. LeBien
Murine and Human IL-7 Activate STAT5 and Induce Proliferation of Normal Human Pro-B Cells
J. Immunol.,
December 1, 2005;
175(11):
7325 - 7331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Bradl, J. Wittmann, D. Milius, C. Vettermann, and H.-M. Jack
Interaction of Murine Precursor B Cell Receptor with Stroma Cells Is Controlled by the Unique Tail of {lambda}5 and Stroma Cell-Associated Heparan Sulfate
J. Immunol.,
September 1, 2003;
171(5):
2338 - 2348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Oritani, S. Hirota, T. Nakagawa, I. Takahashi, S.-i. Kawamoto, M. Yamada, N. Ishida, T. Kadoya, Y. Tomiyama, P. W. Kincade, et al.
T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heat- and acid-stable and heparin-binding glycoprotein
Blood,
January 1, 2003;
101(1):
178 - 185.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kouro, V. Kumar, and P. W. Kincade
Relationships between early B- and NK-lineage lymphocyte precursors in bone marrow
Blood,
November 15, 2002;
100(10):
3672 - 3680.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Iwata, L. Graf, N. Awaya, and B. Torok-Storb
Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein
Blood,
July 30, 2002;
100(4):
1318 - 1325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-Q. Xia and K.-J. Kao
Heparin Induces Differentiation of CD1a+ Dendritic Cells from Monocytes: Phenotypic and Functional Characterization
J. Immunol.,
February 1, 2002;
168(3):
1131 - 1138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Bechard, T. Gentina, M. Delehedde, A. Scherpereel, M. Lyon, M. Aumercier, R. Vazeux, C. Richet, P. Degand, B. Jude, et al.
Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity
J. Biol. Chem.,
December 14, 2001;
276(51):
48341 - 48349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Shah, L. Oseth, H. Tran, B. Hirsch, and T. W. LeBien
Clonal Variation in the B-Lineage Acute Lymphoblastic Leukemia Response to Multiple Cytokines and Bone Marrow Stromal Cells
Cancer Res.,
July 1, 2001;
61(13):
5268 - 5274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kouro, K. L. Medina, K. Oritani, and P. W. Kincade
Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators
Blood,
May 1, 2001;
97(9):
2708 - 2715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Salek-Ardakani, J. R. Arrand, D. Shaw, and M. Mackett
Heparin and heparan sulfate bind interleukin-10 and modulate its activity
Blood,
September 1, 2000;
96(5):
1879 - 1888.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yamashita, K. Oritani, E. K. Miyoshi, R. Wall, M. Bernfield, and P. W. Kincade
Syndecan-4 Is Expressed by B Lineage Lymphocytes and Can Transmit a Signal for Formation of Dendritic Processes
J. Immunol.,
May 15, 1999;
162(10):
5940 - 5948.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
